- A Prospective Study on Rabeprazole-based Triple Therapy for Helicobacter pylori Eradication in Patients with Peptic Ulcer
-
Choi BK, Yang SY, Park ET, Jang YS, Lee YJ, Lee SH, Seol SY, Chung JM
- KMID: 772530
- Korean J Gastroenterol.
- 2003 Aug;42(2):102-107.
BACKGROUND/AIMS: Rabeprazole sodium is a potent proton pump inhibitor. We assessed the efficacy, safety and compliance of one-week triple therapy including rabeprazole with amoxicillin and clarithromycin for eradication of... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Triple Therapy with Rabeprazole for Helicobacter pylori Infection in relation to CYP2C19 Genotype
-
Lee SB, Park SJ, Ryu JK, Lee JK, Kim HJ, Bae JS, Jung HS, Park SM
- KMID: 1066037
- Korean J Gastroenterol.
- 2003 Dec;42(6):468-475.
BACKGROUND/AIMS: Genetic polymorphism of cytochrome P450 CYP2C19 influences the efficacy of proton pump inhibitor (PPI) in Helicobacter pylori (H. pylori) eradication therapy. We investigated the difference in the cure... -
- CITED
-
- Close
- SHARE
-
- Close
